牛胎児血清の世界市場 2024-2028

概要

牛胎児血清市場は2023-2028年に2億9,416万米ドル、予測期間中のCAGRは5.25%で成長すると予測されます。

当レポートでは、牛胎児血清市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、幹細胞アプリケーションの採用の増加、慢性疾患の有病率の増加、畜産業の成長によって牽引されています。

本調査では、細胞ベースの製薬研究におけるアプリケーションの拡大が、今後数年間の牛胎児血清市場成長を牽引する主要因の1つであるとしています。また、疾病管理への注目の高まりと予防医療の採用拡大が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 牛胎児血清の世界市場 2018-2022
• 用途別セグメント分析 2018-2022
• エンドユーザー別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• バイオ医薬品：市場規模と予測 2023-2028
• ヒトおよび動物のワクチン：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：用途別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 製薬会社およびバイオ医薬品会社：市場規模と予測 2023-2028
• 受託調査機関：市場規模と予測 2023-2028
• 学術調査機関：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• デンマーク：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Animal Technologies Inc.
• Atlas Biologicals Inc.
• Bio Techne Corp.
• Corning Inc.
• Danaher Corp.
• Grifols SA
• HiMedia Laboratories Pvt. Ltd.
• Itoham Yonekyu Holdings Inc.
• Merck KGaA
• PAN Biotech
• Rocky Mountain Biologicals
• Sartorius AG
• TCS Biosciences Ltd.
• Thermo Fisher Scientific Inc.
• Tissue Culture Biologicals

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Application - Market share 2023-2028 (%)
• Exhibits31: Data Table on Application - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Application ($ million)
• Exhibits47: Data Table on Market opportunity by Application ($ million)
• Exhibits48: Chart on End-user - Market share 2023-2028 (%)
• Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by End-user
• Exhibits51: Data Table on Comparison by End-user
• Exhibits52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by End-user ($ million)
• Exhibits65: Data Table on Market opportunity by End-user ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ million)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Animal Technologies Inc. - Overview
• Exhibits116: Animal Technologies Inc. - Product / Service
• Exhibits117: Animal Technologies Inc. - Key offerings
• Exhibits118: Atlas Biologicals Inc. - Overview
• Exhibits119: Atlas Biologicals Inc. - Product / Service
• Exhibits120: Atlas Biologicals Inc. - Key offerings
• Exhibits121: Bio Techne Corp. - Overview
• Exhibits122: Bio Techne Corp. - Business segments
• Exhibits123: Bio Techne Corp. - Key offerings
• Exhibits124: Bio Techne Corp. - Segment focus
• Exhibits125: Corning Inc. - Overview
• Exhibits126: Corning Inc. - Business segments
• Exhibits127: Corning Inc. - Key news
• Exhibits128: Corning Inc. - Key offerings
• Exhibits129: Corning Inc. - Segment focus
• Exhibits130: Danaher Corp. - Overview
• Exhibits131: Danaher Corp. - Business segments
• Exhibits132: Danaher Corp. - Key news
• Exhibits133: Danaher Corp. - Key offerings
• Exhibits134: Danaher Corp. - Segment focus
• Exhibits135: Grifols SA - Overview
• Exhibits136: Grifols SA - Business segments
• Exhibits137: Grifols SA - Key offerings
• Exhibits138: Grifols SA - Segment focus
• Exhibits139: HiMedia Laboratories Pvt. Ltd. - Overview
• Exhibits140: HiMedia Laboratories Pvt. Ltd. - Product / Service
• Exhibits141: HiMedia Laboratories Pvt. Ltd. - Key offerings
• Exhibits142: Itoham Yonekyu Holdings Inc. - Overview
• Exhibits143: Itoham Yonekyu Holdings Inc. - Business segments
• Exhibits144: Itoham Yonekyu Holdings Inc. - Key offerings
• Exhibits145: Itoham Yonekyu Holdings Inc. - Segment focus
• Exhibits146: Merck KGaA - Overview
• Exhibits147: Merck KGaA - Business segments
• Exhibits148: Merck KGaA - Key news
• Exhibits149: Merck KGaA - Key offerings
• Exhibits150: Merck KGaA - Segment focus
• Exhibits151: PAN Biotech - Overview
• Exhibits152: PAN Biotech - Product / Service
• Exhibits153: PAN Biotech - Key offerings
• Exhibits154: Rocky Mountain Biologicals - Overview
• Exhibits155: Rocky Mountain Biologicals - Product / Service
• Exhibits156: Rocky Mountain Biologicals - Key offerings
• Exhibits157: Sartorius AG - Overview
• Exhibits158: Sartorius AG - Business segments
• Exhibits159: Sartorius AG - Key news
• Exhibits160: Sartorius AG - Key offerings
• Exhibits161: Sartorius AG - Segment focus
• Exhibits162: TCS Biosciences Ltd. - Overview
• Exhibits163: TCS Biosciences Ltd. - Product / Service
• Exhibits164: TCS Biosciences Ltd. - Key offerings
• Exhibits165: Thermo Fisher Scientific Inc. - Overview
• Exhibits166: Thermo Fisher Scientific Inc. - Business segments
• Exhibits167: Thermo Fisher Scientific Inc. - Key news
• Exhibits168: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits169: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits170: Tissue Culture Biologicals - Overview
• Exhibits171: Tissue Culture Biologicals - Product / Service
• Exhibits172: Tissue Culture Biologicals - Key offerings
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Information sources
• Exhibits179: List of abbreviations

Abstract

The fetal bovine serum market is forecasted to grow by USD 294.16 mn during 2023-2028, accelerating at a CAGR of 5.25% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of stem cell applications, the increasing prevalence of chronic diseases, and livestock industry growth.

Technavio's fetal bovine serum market is segmented as below:

By Application

• Biopharmaceuticals
• Human and animal vaccine
• Others

By End-user

• Pharmaceutical and biopharmaceutical companies
• Contract research organization
• Academic and research organization

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing application in cell-based pharmaceutical research as one of the prime reasons driving the fetal bovine serum market growth during the next few years. Also, increased focus on disease management and the growing adoption of preventive care will lead to sizable demand in the market.

The report on the fetal bovine serum market covers the following areas:

• Fetal bovine serum market sizing
• Fetal bovine serum market forecast
• Fetal bovine serum market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fetal bovine serum market vendors that include Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., Tissue Culture Biologicals, and Celtic Molecular Diagnostics. Also, the fetal bovine serum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global fetal bovine serum market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Biopharmaceuticals - Market size and forecast 2023-2028
• Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
• 6.4 Human and animal vaccine - Market size and forecast 2023-2028
• Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
• 6.5 Others - Market size and forecast 2023-2028
• Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Application
• Exhibit 46: Market opportunity by Application ($ million)
• Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
• Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 7.4 Contract research organization - Market size and forecast 2023-2028
• Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
• 7.5 Academic and research organization - Market size and forecast 2023-2028
• Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Denmark - Market size and forecast 2023-2028
• Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 India - Market size and forecast 2023-2028
• Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Animal Technologies Inc.
• Exhibit 115: Animal Technologies Inc. - Overview
• Exhibit 116: Animal Technologies Inc. - Product / Service
• Exhibit 117: Animal Technologies Inc. - Key offerings
• 12.4 Atlas Biologicals Inc.
• Exhibit 118: Atlas Biologicals Inc. - Overview
• Exhibit 119: Atlas Biologicals Inc. - Product / Service
• Exhibit 120: Atlas Biologicals Inc. - Key offerings
• 12.5 Bio Techne Corp.
• Exhibit 121: Bio Techne Corp. - Overview
• Exhibit 122: Bio Techne Corp. - Business segments
• Exhibit 123: Bio Techne Corp. - Key offerings
• Exhibit 124: Bio Techne Corp. - Segment focus
• 12.6 Corning Inc.
• Exhibit 125: Corning Inc. - Overview
• Exhibit 126: Corning Inc. - Business segments
• Exhibit 127: Corning Inc. - Key news
• Exhibit 128: Corning Inc. - Key offerings
• Exhibit 129: Corning Inc. - Segment focus
• 12.7 Danaher Corp.
• Exhibit 130: Danaher Corp. - Overview
• Exhibit 131: Danaher Corp. - Business segments
• Exhibit 132: Danaher Corp. - Key news
• Exhibit 133: Danaher Corp. - Key offerings
• Exhibit 134: Danaher Corp. - Segment focus
• 12.8 Grifols SA
• Exhibit 135: Grifols SA - Overview
• Exhibit 136: Grifols SA - Business segments
• Exhibit 137: Grifols SA - Key offerings
• Exhibit 138: Grifols SA - Segment focus
• 12.9 HiMedia Laboratories Pvt. Ltd.
• Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
• Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
• Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings
• 12.10 Itoham Yonekyu Holdings Inc.
• Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
• Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
• Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
• Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus
• 12.11 Merck KGaA
• Exhibit 146: Merck KGaA - Overview
• Exhibit 147: Merck KGaA - Business segments
• Exhibit 148: Merck KGaA - Key news
• Exhibit 149: Merck KGaA - Key offerings
• Exhibit 150: Merck KGaA - Segment focus
• 12.12 PAN Biotech
• Exhibit 151: PAN Biotech - Overview
• Exhibit 152: PAN Biotech - Product / Service
• Exhibit 153: PAN Biotech - Key offerings
• 12.13 Rocky Mountain Biologicals
• Exhibit 154: Rocky Mountain Biologicals - Overview
• Exhibit 155: Rocky Mountain Biologicals - Product / Service
• Exhibit 156: Rocky Mountain Biologicals - Key offerings
• 12.14 Sartorius AG
• Exhibit 157: Sartorius AG - Overview
• Exhibit 158: Sartorius AG - Business segments
• Exhibit 159: Sartorius AG - Key news
• Exhibit 160: Sartorius AG - Key offerings
• Exhibit 161: Sartorius AG - Segment focus
• 12.15 TCS Biosciences Ltd.
• Exhibit 162: TCS Biosciences Ltd. - Overview
• Exhibit 163: TCS Biosciences Ltd. - Product / Service
• Exhibit 164: TCS Biosciences Ltd. - Key offerings
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 165: Thermo Fisher Scientific Inc. - Overview
• Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 167: Thermo Fisher Scientific Inc. - Key news
• Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Tissue Culture Biologicals
• Exhibit 170: Tissue Culture Biologicals - Overview
• Exhibit 171: Tissue Culture Biologicals - Product / Service
• Exhibit 172: Tissue Culture Biologicals - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 173: Inclusions checklist
• Exhibit 174: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 175: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 176: Research methodology
• Exhibit 177: Validation techniques employed for market sizing
• Exhibit 178: Information sources
• 13.5 List of abbreviations
• Exhibit 179: List of abbreviations